BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 28555728)

  • 1. Platelet distribution width as the prognostic marker in coronary bifurcation treatment.
    Kern A; Gil RJ; Bojko K; Sienkiewicz E; Januszko-Giergielewicz B; Górny J; Bil J
    Eur J Clin Invest; 2017 Jul; 47(7):524-530. PubMed ID: 28555728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of dual antiplatelet therapy on mean platelet volume in patients with coronary artery disease undergoing percutaneous coronary intervention.
    Higaki T; Kurisu S; Watanabe N; Ikenaga H; Shimonaga T; Iwasaki T; Mitsuba N; Ishibashi K; Dohi Y; Fukuda Y; Kihara Y
    Heart Vessels; 2016 Mar; 31(3):269-74. PubMed ID: 25381477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of platelet indices after acute myocardial infarction treated with primary percutaneous coronary intervention.
    Rechciński T; Jasińska A; Foryś J; Krzemińska-Pakuła M; Wierzbowska-Drabik K; Plewka M; Peruga JZ; Kasprzak JD
    Cardiol J; 2013; 20(5):491-8. PubMed ID: 24469872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet distribution width predicts left ventricular dysfunction in patients with acute coronary syndromes treated with percutaneous coronary intervention.
    Kowara M; Grodecki K; Huczek Z; Puchta D; Paczwa K; Rymuza B; Zbroński K; Filipiak KJ; Opolski G
    Kardiol Pol; 2017; 75(1):42-47. PubMed ID: 27714719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet Distribution Width on Admission Predicts In-Stent Restenosis in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus Treated with Percutaneous Coronary Intervention.
    Hu CP; Du Y; Zhu Y; Shi C; Qin Z; Zhao YX
    Chin Med J (Engl); 2018 Apr; 131(7):757-763. PubMed ID: 29578117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial changes of mean platelet volume in relation to Killip Class in patients with acute myocardial infarction and primary percutaneous coronary intervention.
    Wang XY; Yu HY; Zhang YY; Wang YP; Feng XH; Li ZP; Du XJ; Gao W
    Thromb Res; 2015 Apr; 135(4):652-8. PubMed ID: 25682433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic implications of mean platelet volume on short- and long-term outcomes among patients with non-ST-segment elevation myocardial infarction treated with percutaneous coronary intervention: A single-center large observational study.
    Wasilewski J; Desperak P; Hawranek M; Ciślak A; Osadnik T; Pyka Ł; Gawlita M; Bujak K; Niedziela J; Krawczyk M; Gąsior M
    Platelets; 2016 Jul; 27(5):452-8. PubMed ID: 26939525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Impact of platelet distribution width on the extent and long-term outcome of patients with stable coronary artery disease post percutaneous coronary intervention].
    Jiang P; Song Y; Xu JJ; Ma YL; Tang XF; Yao Y; Jiang L; Wang HH; Zhang X; Diao XL; Yang YJ; Gao RL; Qiao SB; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Oct; 45(10):862-866. PubMed ID: 29081176
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical outcome prediction from mean platelet volume in patients undergoing percutaneous coronary intervention in Korean cohort: Implications of more simple and useful test than platelet function testing.
    Choi SW; Choi DH; Kim HW; Ku YH; Ha SI; Park G
    Platelets; 2014; 25(5):322-7. PubMed ID: 23909871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
    Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G
    Expert Opin Pharmacother; 2015; 16(12):1739-47. PubMed ID: 26067422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Routine assessment of on-clopidogrel platelet reactivity and gene polymorphisms in predicting clinical outcome following drug-eluting stent implantation in patients with stable coronary artery disease.
    Viviani Anselmi C; Briguori C; Roncarati R; Papa L; Visconti G; Focaccio A; De Micco F; Latronico MV; Pagnotta P; Condorelli G
    JACC Cardiovasc Interv; 2013 Nov; 6(11):1166-75. PubMed ID: 24262617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of platelet indices to severity of coronary artery disease in patients undergoing primary percutaneous coronary intervention.
    Akin F; Ayca B; Kose N; Altun I; Avsar M; Celik O; Satilmis S; Eksik A; Okuyan E
    Perfusion; 2016 Apr; 31(3):216-22. PubMed ID: 26178072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttreatment platelet reactivity on clopidogrel is associated with the risk of adverse events after off-pump coronary artery bypass.
    Youn YN; Yi G; Lee S; Joo HC; Yoo KJ
    Am Heart J; 2014 Jun; 167(6):818-25. PubMed ID: 24890530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination between mean platelet volume and platelet distribution width to predict the prevalence and extent of coronary artery disease: results from a large cohort study.
    De Luca G; Secco GG; Verdoia M; Cassetti E; Schaffer A; Coppo L; Marino P
    Blood Coagul Fibrinolysis; 2014 Jan; 25(1):86-91. PubMed ID: 24126247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Change of platelet parameters in septic shock patients].
    Gao Y; Li L; Li Y; Yu X; Sun T; Lan C
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Jan; 26(1):28-32. PubMed ID: 24506853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).
    Gupta R; Kirtane AJ; Ozan MO; Witzenbichler B; Rinaldi MJ; Metzger DC; Weisz G; Stuckey TD; Brodie BR; Mehran R; Ben-Yehuda O; Stone GW
    Circ Cardiovasc Interv; 2017 Mar; 10(3):. PubMed ID: 28288963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of mean platelet volume in patients undergoing elective percutaneous coronary intervention.
    Seyyed-Mohammadzad MH; Eskandari R; Rezaei Y; Khademvatani K; Mehrpooya M; Rostamzadeh A; Zahedi A
    Anatol J Cardiol; 2015 Jan; 15(1):25-30. PubMed ID: 25179882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive cilostazol versus double-dose clopidogrel after drug-eluting stent implantation: the HOST-ASSURE randomized trial (Harmonizing Optimal Strategy for Treatment of Coronary Artery Stenosis-Safety & Effectiveness of Drug-Eluting Stents & Anti-platelet Regimen).
    Park KW; Kang SH; Park JJ; Yang HM; Kang HJ; Koo BK; Park BE; Cha KS; Rhew JY; Jeon HK; Shin ES; Oh JH; Jeong MH; Kim S; Hwang KK; Yoon JH; Lee SY; Park TH; Moon KW; Kwon HM; Chae IH; Kim HS
    JACC Cardiovasc Interv; 2013 Sep; 6(9):932-42. PubMed ID: 24050860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mean Platelet Volume and Major Adverse Cardiac Events following Percutaneous Coronary Intervention.
    Nozari Y; Parsa M; Jalali A; Ariannejad H; Shafiee A
    Arch Iran Med; 2019 Apr; 22(4):198-203. PubMed ID: 31126178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Value of Mean Platelet Volume/Platelet Count for Prognosis in Acute Myocardial Infarction.
    Tian C; Song J; He D; Wu J; Sun Z; Sun Z
    Int Heart J; 2018 Mar; 59(2):286-292. PubMed ID: 29563382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.